GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » ROE % Adjusted to Book Value

AegirBio AB (AegirBio AB) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB ROE % Adjusted to Book Value?

AegirBio AB's ROE % for the quarter that ended in Mar. 2024 was 0.00%. AegirBio AB's PB Ratio for the quarter that ended in Mar. 2024 was N/A. AegirBio AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.


AegirBio AB ROE % Adjusted to Book Value Historical Data

The historical data trend for AegirBio AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB ROE % Adjusted to Book Value Chart

AegirBio AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - - - -

AegirBio AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -57.84 -64.13 - -

Competitive Comparison of AegirBio AB's ROE % Adjusted to Book Value

For the Medical Devices subindustry, AegirBio AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AegirBio AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AegirBio AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where AegirBio AB's ROE % Adjusted to Book Value falls into.



AegirBio AB ROE % Adjusted to Book Value Calculation

AegirBio AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-314.94% / N/A
=N/A

AegirBio AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AegirBio AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of AegirBio AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


AegirBio AB (AegirBio AB) Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines